Pediatric Blood & Cancer · 2022 · 18 citations · 13 references
MedicineChild HealthOncologyHealth EquityOutcomes ResearchPediatric OncologyCancer Health DisparitiesClinical TrialsClinical Trials In OncologyEquity AssessmentHealth Equity MeasurementPediatric Cancer EpidemiologyHealth Equity AnalysisHealth Outcome DisparitiesLongitudinal Response AssessmentLongitudinal Response MonitoringPediatric Oncology TrialsTranslational Clinical Trial Design
Social determinants of health (SDoH) are associated with stark disparities in cancer outcomes, but systematic SDoH data collection is virtually absent from oncology clinical trials. Trial-based SDoH data are essential to ensure representation of marginalized populations, contextualize outcome disparities, and identify health-equity intervention opportunities. We report the feasibility of a pediatric oncology multicenter therapeutic trial-embedded SDoH investigation. Among 448 trial participants, 392 (87.5%) opted-in to the embedded SDoH study; 375 (95.7%) completed baseline surveys, with high longitudinal response rates (88.9-93.1%) over 24 months. Trial-embedded SDoH data collection is feasible and acceptable and must be consistently included within future oncology trials.
13
Gopal K. Singh, Ahmedin Jemal · Journal of Environmental and Public Health · 2017 · 761 citations · Full text
Medicine, Demography, Oncology +17
Paula Aristizabal, Lena E. Winestone, Puja J. Umaretiya et al. · American Society of Clinical Oncology Educational Book · 2021 · 105 citations · Full text
Public Health, Oncology, Pediatrics +15